C20H12I6N2O6.C7H18NO5.C7H18NO5
|
InChI=1S/C20H14I6N2O6.2C7H17NO5/c21- 7- 5- 9(23) 17(15(25) 13(7) 19(31) 32) 27- 11(29) 3- 1- 2- 4- 12(30) 28- 18- 10(24) 6- 8(22) 14(16(18) 26) 20(33) 34;2*1- 8- 2- 4(10) 6(12) 7(13) 5(11) 3- 9/h5- 6H,1- 4H2,(H,27,29) (H,28,30) (H,31,32) (H,33,34) ;2*4- 13H,2- 3H2,1H3/t;2*4- ,5+,6+,7+/m.00/s1 |
DGIAUNUPXILTJW-VRWDCWMNSA-N |
OC[C@@H] (O) [C@H] ([C@H] (O) [C@H] (C[NH2+] C) O) O.OC[C@@H] (O) [C@H] ([C@H] (O) [C@H] (C[NH2+] C) O) O.C1=C(C(=C(C(=C1I) NC(=O) CCCCC(=O) NC2=C(C=C(C(=C2I) C([O- ] ) =O) I) I) I) C([O- ] ) =O) I |
|
radioopaque medium
A substance having the property of absorbing, and therefore being opaque to, electromagnetic radiation, particularly X-rays.
|
|
View more via ChEBI Ontology
bis[1- deoxy- 1- (methylazaniumyl)- D- glucitol] 3,3'- [(1,6- dioxohexane- 1,6- diyl)diimino]bis(2,4,6- triiodobenzoate)
|
adipiodone meglumine
|
DrugBank
|
adipiodone meglumine injection
|
ChemIDplus
|
iodipamide meglumine
|
ChemIDplus
|
iodipamide meglumine
|
KEGG DRUG
|
iodipamide meglumine salt
|
ChemIDplus
|
iodipamide methylglucamine salt
|
ChemIDplus
|
meglumine adipiodone
|
DrugBank
|
meglumine iodipamide
|
DrugBank
|
methyl glucamine biligrafin
|
DrugBank
|
methylglucamine iodipamide
|
DrugBank
|
Biligrafin forte
|
ChemIDplus
|
Cavumbren
|
ChEBI
|
Cavumbren
|
ChemIDplus
|
Cholografin meglumine
|
KEGG DRUG
|
Endocistobil
|
ChemIDplus
|
Endografin
|
ChemIDplus
|
Endographin
|
ChemIDplus
|
Intrabillix
|
ChEBI
|
Intrablix
|
ChemIDplus
|
Sinografin
|
ChEBI
|
Transbillix
|
ChemIDplus
|
Ultrabil
|
ChemIDplus
|
3521-84-4
|
CAS Registry Number
|
KEGG COMPOUND
|
3521-84-4
|
CAS Registry Number
|
ChemIDplus
|
|